Health CareHealth Care Equipment & Services
  • Price (NOK)32.92
  • Today's Change-0.48 / -1.44%
  • Shares traded68.83k
  • 1 Year change-39.70%
  • Beta1.0904
Data delayed at least 15 minutes, as of Sep 23 2019 10:00 BST.
More ▼

Events & Activity

  • NANO:OSL price falls below 50-day moving average to 32.34 at 10:01 BST
  • NANO:OSL price rises above 50-day moving average to 32.42 at 13:27 BST
  • NANO:OSL price moved over +1.51% to 36.28
  • NANO:OSL price falls below 50-day moving average to 32.38 at 10:03 BST
  • NANO:OSL trading volume exceeds daily average by +15.44%

Key statistics

As of last trade, Nordic Nanovector ASA (NANO:OSL) traded at 32.92, 48.82% above the 52 week low of 22.12 set on Aug 27, 2019.
52-week range
22.12Aug 27 201989.53Nov 29 2018
Markit short selling activity
Previous close33.40
Average volume816.06k
Shares outstanding55.11m
Free float46.37m
P/E (TTM)--
Market cap1.84bn NOK
EPS (TTM)-7.12
Data delayed at least 15 minutes, as of Sep 23 2019 10:00 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.